Global Obesity Intervention Devices Market: Trends, Growth, and Future Outlook

https://www.alliedmarketresearch.com/obesity-intervention-devices-market

Market Overview
• The global obesity intervention devices market was valued at $243.2 million in 2021 and is projected to reach $407.6 million by 2031.
• The market is expected to grow at a CAGR of 5.3% from 2022 to 2031.
• Obesity intervention devices help manage obesity by limiting food intake or altering food digestion, leading to weight loss.
• Key devices include:
• Gastric Bands - Adjustable silicone bands restricting stomach capacity.
• Gastric Balloons - Inflatable silicone balloons that occupy stomach space.
• Gastric Stimulator Systems - Devices that stimulate stomach muscles to aid weight loss.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/5480

Market Drivers
1. Rising Prevalence of Obesity
• Obesity rates are increasing worldwide, boosting the demand for intervention devices.
• According to the World Obesity Federation (2020):
• 1 billion people globally suffer from obesity.
• By 2030, 1 in 5 women and 1 in 7 men will be living with obesity.
• The U.S. reported an increase in obesity prevalence from 36% (2020) to 41% (2021).

2. Increasing Cases of Type 2 Diabetes
• Obesity is a major risk factor for type 2 diabetes, driving demand for obesity intervention devices.
• In 2021, the International Diabetes Federation reported:
• 537 million adults (20-79 years) were living with diabetes worldwide.
• This number is expected to reach 643 million by 2030 and 783 million by 2045.
• Devices like the LAP-BAND AP Adjustable Gastric Banding System have shown improvements or remission of type 2 diabetes in patients with high BMI.

3. Growing Awareness of Obesity-Related Health Risks
• Obesity is linked to:
• Increased risk of heart disease, stroke, and cancer.
• Mental health issues like depression and anxiety.
• Mobility impairments and joint pain.
• According to Practo (2020), India witnessed a 550% increase in obesity-related queries, highlighting growing public awareness.

Market Challenges
• Side Effects of Obesity Intervention Devices
• Potential issues include nausea, vomiting, abdominal pain, reflux, and intestinal blockage.
• Such side effects may hinder market adoption.
Market Segmentation
By Device
• Gastric Balloons - Dominated the market in 2021 due to an increase in product approvals and launches.
• Gastric Bands - Continue to be a key player in obesity intervention.
• Gastric Stimulator Systems - Expected to see growing adoption due to technological advancements.

By End User
• Hospitals - Leading segment due to the availability of trained medical staff and increased patient admissions.
• Others (Gastroenterology Clinics & Ambulatory Surgical Centers) - Also seeing growth due to rising demand for non-hospital treatments.

Regional Analysis
North America
• Largest market due to:
• High prevalence of obesity.
• Presence of key industry players.
• Increase in product approvals (e.g., ReShape Lifesciences' FDA approval for GIBI HD calibration tube in 2022).

Asia-Pacific
• Fastest-growing region due to:
• Rising obesity rates in countries like India and China.
• Growing diabetes prevalence (90 million in Southeast Asia in 2021, expected to reach 151 million by 2045).

Key Market Players
• Apollo Endosurgery
• Reshape Lifesciences
• GI Dynamics
• Allergan
• Johnson & Johnson
• Allurion Technologies, Inc.
• Asensus Surgical

Recent Market Developments

• August 2022: ReShape Lifesciences received FDA 510(k) approval for its gastrointestinal balloon indicator (GIBI HD), enhancing gastric and bariatric procedures.

Future Outlook
• Continued technological advancements will drive market growth.
• Increasing awareness and early intervention strategies will boost demand.
• Regulatory approvals and new product launches will shape the competitive landscape.

The global obesity intervention devices market is poised for steady growth, fueled by rising obesity rates, increasing diabetes prevalence, and growing awareness of obesity-related health risks. However, addressing device-related side effects will be crucial for long-term adoption and success.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/5480

Contact Us:

United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the report

This release was published on openPR.